Form 8-K - Current report:
SEC Accession No. 0001193125-21-252071
Filing Date
2021-08-20
Accepted
2021-08-20 08:01:10
Documents
12
Period of Report
2021-08-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d172325d8k.htm   iXBRL 8-K 25696
  Complete submission text file 0001193125-21-252071.txt   152509

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dsgn-20210818.xsd EX-101.SCH 2892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dsgn-20210818_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dsgn-20210818_pre.xml EX-101.PRE 11860
5 EXTRACTED XBRL INSTANCE DOCUMENT d172325d8k_htm.xml XML 3481
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 211191723
SIC: 2834 Pharmaceutical Preparations